BiotechTube
Home/CytoAgents/Michael Howell
MH

Michael Howell

Chief Scientific Officer

CytoAgents

Therapeutic Areas

Oncology Supportive CareImmunologyInflammatory Diseases

CytoAgents Pipeline

DrugIndicationPhase
CTO1681CAR T-Cell/TCE Therapy-Related Inflammation (CRS/ICANS)Phase 1b/2a

Leadership Team at CytoAgents

DJ
Dr. Johannes Wolff
Chief Medical Officer
View full CytoAgents profile